DR. RODNEY PERKINS, M.D.
Medical Practice at Woodside Rd, Redwood City, CA
License number
California C24414
Category
Medical Practice
Type
Otology & Neurotology
Address
Address
2995 Woodside Rd SUITE 100, Redwood City, CA 94062
Phone
(650) 323-0300
(650) 529-0220 (Fax)
(650) 529-0220 (Fax)
Organization information
See more information about RODNEY PERKINS at bizstanding.comRodney Perkins, M.D. Professional Corporation
Redwood City, CA
Industry:
Ent
Doing business as:
Rodney Perkins MD
Registration:
Mar 3, 2014
Phone:
(650) 561-9275 (Phone)
Addresses:
200 Chesapeake Dr, Redwood City, CA 94063
2995 Woodside Rd, Redwood City, CA 94062
2995 Woodside Rd, Redwood City, CA 94062
State ID:
03651007
Business type:
Articles of Incorporation
Presidents:
Rodney C. Perkins (President),Perkins Rodney President, inactive
Rodney Perkins Associate
2995 Woodside Rd STE 100, Woodside, CA 94062
Phone:
(650) 323-0300 (Phone)
Professional information
Dr. Rodney C Perkins, Redwood City CA - MD (Doctor of Medicine)
Specialties:
Neurotology
Address:
2995 Woodside Rd STE 100, Redwood City 94062
Languages:
English
Education:
Medical School
Indiana University / School of Medicine
Graduated: 1961
Indiana University / School of Medicine
Graduated: 1961
Methods Of Endobronchial Diagnosis Using Imaging
US Patent:
2003005, Mar 20, 2003
Filed:
Sep 11, 2002
Appl. No.:
10/241974
Inventors:
Robert Kotmel - Burlingame CA, US
Peter Soltesz - San Jose CA, US
Anthony Wondka - Mountain View CA, US
Rodney Perkins - Woodside CA, US
Peter Soltesz - San Jose CA, US
Anthony Wondka - Mountain View CA, US
Rodney Perkins - Woodside CA, US
Assignee:
PULMONx - Palo Alto CA
International Classification:
A61B005/05
US Classification:
600/410000, 600/443000
Abstract:
Devices and methods are provided for acquiring and analyzing an image data file to generate diagnostic information reflecting an individual lung compartment. A lung compartment could be an entire lobe, a segment or a subsegment and beyond, hereinafter subsegments and beyond will be referred to simply as segments. Such analysis is used to assess the level of disease of individual lung compartments, both for quantification of the disease state and for determining the most appropriate treatment plan. This analysis allows the imaging technology to be used as a functional diagnostic tool as well as an anatomical diagnostic tool. To this end, dynamic data or images may also be acquired at specific points throughout the breathing cycle. Since air movement in and out of a lung compartment during the breathing cycle is a direct indicator of lung function in some diseases like emphysema, analysis of images during the breathing cycle will indicate levels of disease. Thus, a physician may be able to determine the nature of the disease, severity of the disease and the most effective course of treatment from a computerized image of the lung.
Optically Coupled Acoustic Middle Ear Implant Systems And Methods
US Patent:
2010031, Dec 9, 2010
Filed:
Jun 7, 2010
Appl. No.:
12/794969
Inventors:
Sunil Puria - Sunnyvale CA, US
Rodney C. Perkins - Woodside CA, US
Paul Rucker - San Francisco CA, US
Rodney C. Perkins - Woodside CA, US
Paul Rucker - San Francisco CA, US
Assignee:
SoundBeam LLC - Redwood City CA
International Classification:
A61F 11/00, H04R 25/00
US Classification:
600 25
Abstract:
An assembly comprising a sound transducer can be implanted in the middle ear in a manner that simplifies surgery. The assembly may comprise a narrow cross-sectional profile such that the assembly can be positioned in the middle ear through an incision in the eardrum, for example without cutting bone. The incision can be closed and electromagnetic energy transmitted through the closed incision to a transducer configured to vibrate the ear in response to the electromagnetic energy. In many embodiments, the sound transducer comprises a speaker positioned in the middle ear, and the sound transducer can couple to vibratory structure of the ear with air so as to simplify surgery. The assembly may be affixed to a substantially fixed structure of the ear, for example the promontory, so as to inhibit user perceivable occlusion and inhibit motion of the assembly, such that the user can perceive clear sound with little occlusion.
Optically Coupled Active Ossicular Replacement Prosthesis
US Patent:
2010031, Dec 16, 2010
Filed:
Jun 14, 2010
Appl. No.:
12/814998
Inventors:
Sunil Puria - Sunnyvale CA, US
Rodney C. Perkins - Woodside CA, US
Rodney C. Perkins - Woodside CA, US
Assignee:
SoundBeam LLC - Redwood City CA
International Classification:
H04R 25/00
US Classification:
600 25
Abstract:
An active ossicular replacement device is configured to couple the malleus to the stapes, and conduct sound through the vibratory structures of the ear in response to the transmitted electromagnetic energy. The electromagnetic energy may comprise light so as to decrease interference from sources of noise external to the user. The prosthetic device may comprise an assembly that can be implanted in the middle ear in a manner that simplifies surgery. The assembly may comprise a narrow cross-sectional profile such that the assembly can be positioned in the middle ear through an incision in the eardrum, for example without cutting bone that defines the shape of the ear canal or the shape of the middle ear. The prosthetic device can be sized to the user based on a measurement of the ear.
Minimally Invasive Methods And Devices For The Treatment Of Prostate Diseases
US Patent:
2013026, Oct 10, 2013
Filed:
Mar 8, 2013
Appl. No.:
13/790144
Inventors:
Rodney C. PERKINS - Woodside CA, US
International Classification:
A61B 17/3203, A61B 18/18, A61B 18/14, A61B 18/20
US Classification:
604 22, 606190, 606 14, 606 33, 606 41
Abstract:
Methods and systems for resecting and debulking prostatic tissue to utilize a shaft carrying an energy source. The shaft is anchored by a balloon or other structure expanded in the bladder, and the energy source is capable of directing ablative energy radially outwardly from the urethra, where the energy source will be moved in order to remove a pre-defined volume of prostatic tissue.
Methods, Systems, And Kits For Lung Volume Reduction
US Patent:
7766895, Aug 3, 2010
Filed:
Apr 12, 2005
Appl. No.:
11/104717
Inventors:
Peter P. Soltesz - Henderson NV, US
Anthony D. Wondka - Thousand Oaks CA, US
Rodney A. Perkins - Woodside CA, US
Robert Kotmel - Burlingame CA, US
Anthony D. Wondka - Thousand Oaks CA, US
Rodney A. Perkins - Woodside CA, US
Robert Kotmel - Burlingame CA, US
Assignee:
Pulmonx Corporation - Redwood City CA
International Classification:
A61M 31/00
US Classification:
604516
Abstract:
Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.
Methods And Systems For Occluding Collateral Flow Channels In The Lung
US Patent:
8137302, Mar 20, 2012
Filed:
Mar 12, 2007
Appl. No.:
11/684950
Inventors:
Nikolai Aljuri - Revere MA, US
Jose G. Venegas - Swapscott MA, US
Ajit Nair - Milipitas CA, US
Rodney C. Perkins - Woodside CA, US
Jose G. Venegas - Swapscott MA, US
Ajit Nair - Milipitas CA, US
Rodney C. Perkins - Woodside CA, US
Assignee:
Pulmonx Corporation - Redwood City CA
International Classification:
A61M 16/00
US Classification:
604 24
Abstract:
The lateral flow between adjacent lung segments is occluded by blocking collateral flow channels with particles. A gas flow is established from one lung segment through the flow channels in an intermediate fibrous septum, and out through the adjacent lung segment. Particles entrained in the gas flow become lodged in the collateral flow channels to eventually block flow.
Minimally Invasive Determination Of Collateral Ventilation In Lungs
US Patent:
2013024, Sep 19, 2013
Filed:
May 10, 2013
Appl. No.:
13/891719
Inventors:
Nikolai Aljuri - Hillsborough CA, US
Anthony Wondka - Thousand Oaks CA, US
George Surjan - San Jose CA, US
Kirk Davis - Los Gatos CA, US
Peter Soltesz - Henderson NV, US
Rodney C. Perkins - Woodside CA, US
Anthony Wondka - Thousand Oaks CA, US
George Surjan - San Jose CA, US
Kirk Davis - Los Gatos CA, US
Peter Soltesz - Henderson NV, US
Rodney C. Perkins - Woodside CA, US
Assignee:
Pulmonx Corporation - Redwood City CA
International Classification:
A61B 5/085, A61B 5/00, A61B 5/087
US Classification:
600533
Abstract:
Minimally invasive methods, systems and devices are provided for qualitatively and quantitatively assessing collateral ventilation in the lungs. In particular, collateral ventilation of a target compartment within a lung of a patient is assessed by advancement of a catheter through the tracheobronchial tree to a feeding bronchus of the target compartment. The feeding bronchus is occluded by the catheter and a variety of measurements are taken with the use of the catheter in a manner which is of low risk to the patient. Examples of such measurements include but are not limited to flow rate, volume and pressure. These measurements are used to determine the presence of collateral ventilation and to quantify such collateral ventilation.
Minimally Invasive Biological Vessel Harvesting Method
US Patent:
5970982, Oct 26, 1999
Filed:
Feb 20, 1997
Appl. No.:
8/804246
Inventors:
Rodney C. Perkins - Woodside CA
International Classification:
A61B 1900
US Classification:
128898
Abstract:
A method is provided for ligating a segment of a biological vessel having a proximal end and a distal end. According to the method, the distal end of the vessel segment to be ligated is accessed; an inner fluid delivery catheter is attached to the distal end of the vessel segment; fluid is infused into the biological vessel; the vessel segment is advanced within a lumen of an outer catheter, the outer catheter including a cautery-sectioning system; tributaries extending from the vessel segment are cauterized and sectioned with the cautery-sectioning system as the vessel segment is advanced within the outer catheter; and the vessel segment proximal end is ligated.
Hearing System Having An Open Chamber For Housing Components And Reducing The Occlusion Effect
US Patent:
7668325, Feb 23, 2010
Filed:
May 3, 2005
Appl. No.:
11/121517
Inventors:
Sunil Puria - Sunnyvale CA, US
Rodney C. Perkins - Woodside CA, US
Rodney C. Perkins - Woodside CA, US
Assignee:
EarLens Corporation - Palo Alto CA
International Classification:
H04R 25/00
US Classification:
381322, 381328, 181135
Abstract:
A hearing system comprises a shell having an open inner chamber. An input transducer and a transmitter assembly are disposed in the open inner chamber. The transmitter has a frequency response bandwidth in a 6 kHz to 20 kHz range, and the open chamber has an end adjacent a patient's tympanic membrane with one or more openings that allow the ambient sound to pass through the chamber and directly reach the middle ear of the user.